Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
09/11/2012 | US8262991 Apparatus for analysing fluid taken from a body |
09/11/2012 | US8262283 Apparatus and method for determining the thermal stability of fluids |
09/11/2012 | US8261981 Apparatus and methods for monitoring transfusion of blood |
09/11/2012 | CA2650281C Microwave assisted deglycosylation of proteins for molecular weight determination by mass spectrometry |
09/11/2012 | CA2614142C Detection of rho proteins |
09/11/2012 | CA2525286C Materials and methods relating to g-protein coupled receptor oligomers |
09/11/2012 | CA2493588C Functional cardiomyocytes from human embryonic stem cells |
09/11/2012 | CA2493440C Method for making biochips |
09/11/2012 | CA2491864C Super humanized antibodies |
09/11/2012 | CA2491726C Feline infectious peritonitis vaccine |
09/11/2012 | CA2473747C Fluorogenic dyes |
09/11/2012 | CA2395291C Five-helix protein |
09/11/2012 | CA2374180C Methods and materials for generating sh3 domains with tailored binding properties |
09/11/2012 | CA2343839C Cytokine receptor zalpha11 |
09/11/2012 | CA2257247C Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same |
09/07/2012 | WO2012119113A2 Prediction of drug sensitivity of lung tumors based on molecular and genetic signatures |
09/07/2012 | WO2012119095A1 Fus1/tusc2 therapies |
09/07/2012 | WO2012118999A1 Assays for antibodies which bind to therapeutic agents |
09/07/2012 | WO2012118969A2 Method of selecting cancer patients for anti-angiogenesis therapy in combination with chemotherapy |
09/07/2012 | WO2012118936A1 Measuring coking propensity |
09/07/2012 | WO2012118930A2 Stable colloidal gold nanoparticles with controllable surface modification and functionalization |
09/07/2012 | WO2012118928A2 Glycoprofiling with multiplexed suspension arrays |
09/07/2012 | WO2012118915A2 Compositions and methods for treatment of tamoxifen resistant breast cancer |
09/07/2012 | WO2012118908A1 Assessment of opioid receptor ligands |
09/07/2012 | WO2012118866A2 Methods to build 3d digital models of porous media using a combination of high- and low-resolution data and multi-point statistics |
09/07/2012 | WO2012118863A1 Therapies that target autoimmunity for treating glaucoma and optic neuropathy |
09/07/2012 | WO2012118856A1 Gene expression signature in skin predicts response to mycophenolate mofetil |
09/07/2012 | WO2012118806A2 Compositions and methods for detecting and treating cancer |
09/07/2012 | WO2012118800A2 Enhancing endotoxin detection |
09/07/2012 | WO2012118693A1 Methods of diagnosing clostridium difficile infection |
09/07/2012 | WO2012118663A1 Predicting toxicity of a compound over a range of concentrations |
09/07/2012 | WO2012118547A1 Novel modulators and methods of use |
09/07/2012 | WO2012118539A2 Automated particulate concentration system |
09/07/2012 | WO2012118444A1 Novel compounds with photoluminescnce properties and applications thereof |
09/07/2012 | WO2012118433A1 Screening method |
09/07/2012 | WO2012118428A1 Sample preservation method and sample application substrate |
09/07/2012 | WO2012118388A1 Peptide-lipid constructs and their use in a fc-function assay |
09/07/2012 | WO2012118226A1 An agent for measuring endotoxin |
09/07/2012 | WO2012118088A1 Method for detecting recurrent prostate cancer |
09/07/2012 | WO2012117699A1 Biological sample measurement device |
09/07/2012 | WO2012117689A1 Information terminal device and biological sample measurement device |
09/07/2012 | WO2012117588A1 Multiple substances-responsive gel, method for producing same, and utilization of same |
09/07/2012 | WO2012117504A1 Water absorbent material |
09/07/2012 | WO2012117387A1 Method of labeling neurons and its application |
09/07/2012 | WO2012117382A1 Method for detecting parvovirus antigen |
09/07/2012 | WO2012117367A1 Probe and primer sequences for detection of hepatitis b virus by real-time pcr, pcr reaction mixture and kits thereof. |
09/07/2012 | WO2012117342A1 Depleted anti-staphylococcal enterotoxins polyclonal antibodies, preparation and uses thereof |
09/07/2012 | WO2012117341A1 Process for the determination of the total acidity number (tan) of a mineral insulating oil |
09/07/2012 | WO2012117332A1 Substance determining apparatus |
09/07/2012 | WO2012117269A1 Method for diagnosing acute basophilic leukemia |
09/07/2012 | WO2012117245A1 Identification of small -molecule candidate therapeutics capable of inhibiting or interfering with a target protein- protein interaction |
09/07/2012 | WO2012117162A1 Porosity measurement |
09/07/2012 | WO2012117107A1 Method of determining wether a subject is resistant to chemotherapy with dna damaging agents |
09/07/2012 | WO2012117029A1 Handheld device for electrophysiological analysis |
09/07/2012 | WO2012116979A1 Method of diagnosing breast carcinoma |
09/07/2012 | WO2012116949A1 Application of quantum dots for nuclear staining |
09/07/2012 | WO2012116913A1 Magnetic flow cytometry for high sample throughput |
09/07/2012 | WO2012116906A1 Miniaturized magnetic flow cytometry |
09/07/2012 | WO2012116809A1 Il-22 as a prognostic and diagnostic marker in rheumatoid arthritis |
09/07/2012 | WO2012116780A1 Method for producing a test element for studying a body fluid sample, and test element |
09/07/2012 | WO2012116432A1 Treatment of cancer with dopamine receptor antagonists |
09/07/2012 | WO2012097123A3 New uses of cyclophilin inhibitors |
09/07/2012 | WO2012096436A3 Lung injury model animal caused by hyperoxia exposure, and kit for diagnosing lung injury caused by hyperoxia exposure using a taz marker |
09/07/2012 | WO2012087005A3 Fluorescent nano particles using a lanthanide metal complex and method for preparing same |
09/07/2012 | WO2012086978A3 Cylinder channel having a sawtooth-shaped cross section, coaxial channel including same, and method for manufacturing same |
09/07/2012 | WO2012081911A3 Saliva purifying method |
09/07/2012 | WO2012079030A3 Bioconjugation using bifunctional linkers |
09/07/2012 | WO2012079003A9 Biomarkers for Tuberculosis and HIV/AIDS |
09/07/2012 | WO2012078648A3 Novel method of cancer diagnosis and prognosis and prediction of response to therapy |
09/07/2012 | WO2012073009A3 Nanopore devices |
09/07/2012 | WO2012072987A3 Assay assembly and method |
09/07/2012 | WO2012071472A3 Multi-directional microfluidic devices comprising a pan-capture binding region and methods of using the same |
09/07/2012 | WO2012070860A3 Microvalve using surface tension, microfluidic chip comprising same, and method for manufacturing same |
09/07/2012 | WO2012068562A3 Compositions and methods for detection and treatment of b-raf inhibitor-resistant melanomas |
09/07/2012 | WO2012067460A3 Method for screening for materials for promoting the differentiation of skin cells |
09/07/2012 | WO2012057567A3 Kit for screening for skin-activating substances and comprising the klotho gene, and method for screening for skin-activating substances using same |
09/07/2012 | WO2012038932A3 Kits for detecting breast or ovarian cancer in a body fluid sample and use thereof |
09/07/2012 | WO2012023033A3 Mch-i restricted epitopes containing non-natural amino acid residues |
09/07/2012 | WO2012009026A3 Novel methods of protein evolution |
09/07/2012 | CA2864394A1 Fus1/tusc2 therapies |
09/07/2012 | CA2828972A1 Interrogatory cell-based assays and uses thereof |
09/07/2012 | CA2828935A1 Method for detecting parvovirus antigen |
09/07/2012 | CA2828294A1 Magnetic flow cytometry for high sample throughput |
09/07/2012 | CA2828288A1 Miniaturized magnetic flow cytometry |
09/07/2012 | CA2828052A1 Prediction of drug sensitivity of lung tumors based on molecular and genetic signatures |
09/07/2012 | CA2827859A1 Biological markers and methods for predicting response to b-cell antagonists |
09/07/2012 | CA2827246A1 Process for the determination of the total acidity number (tan) of a mineral insulating oil |
09/07/2012 | CA2824355A1 Application of quantum dots for nuclear staining |
09/07/2012 | CA2820885A1 Novel modulators and methods of use |
09/06/2012 | US20120227134 Plants with Increased Yield |
09/06/2012 | US20120227118 Mo-1 conditional knock-out non-human animal and uses thereof |
09/06/2012 | US20120226446 Systems and methods for monitoring the use of medications |
09/06/2012 | US20120226116 Test media cassette for bodily fluid testing device |
09/06/2012 | US20120225955 Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin |
09/06/2012 | US20120225954 Methods and compositions for the classification of non-small cell lung carcinoma |
09/06/2012 | US20120225928 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
09/06/2012 | US20120225864 Methods and Compositions for Modulating Tau Levels |
09/06/2012 | US20120225820 Peptides associated with hla-dr mhc class ii molecule and involved in rheumatoid arthritis |
09/06/2012 | US20120225795 Protein markers for detecting liver cancer and method for identifying the markers thereof |
09/06/2012 | US20120225794 Antibodies Specific to Heterodimers of Bcl-2 Family and Uses Thereof |